Combine TACE and RFA Versus TACE Alone for HCC With PVTT
Status:
Unknown status
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether combined radiofrequency ablation and
transcatheter chemoembolization (TACE) result in better survival outcomes than TACE alone in
patients with HCC and portal vein tumor thrombus.